Clinical Trial Update: FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFOX6 as neoadjuvant chemotherapy for locally advanced gastric cancer. The trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Gastric Cancer, Effects of Chemotherapy | Phase 2 | Status: UNKNOWN